Economy/Home · Economy

[Breaking] Lemon Healthcare, Hyosung Chemical, Sejong Telecom, and 3 Others Hit Upper Limits... Individual Stocks Maintain Strong Momentum

Upper-limit stocks continue to emerge in the domestic stock market, sustaining a strong trend centered on individual stocks. As of mid-session, stocks across va

Wooil Shim
Staff Reporter
4 min read
[Breaking] Lemon Healthcare, Hyosung Chemical, Sejong Telecom, and 3 Others Hit Upper Limits... Individual Stocks Maintain Strong Momentum
CBC News

Upper-limit stocks continue to emerge in the domestic stock market, sustaining a strong trend centered on individual stocks. As of mid-session, stocks across various sectors—including healthcare, chemicals, telecommunications, and construction—surged to their daily price limits, drawing investor attention.

A total of six stocks reached the upper limit today: Lemon Healthcare, SY, Seosan, Hyosung Chemical, Sejong Telecom, and KPM Tech. These stocks recorded gains of approximately 29.8 to 30.0%, reaching their price limits.

The most notable stock was Lemon Healthcare. It rose 30.00% from the previous trading day to 12,220 won, with trading volume exceeding 22.51 million shares, reflecting strong market interest. Hyosung Chemical also surged 29.84% to 67,000 won to hit the upper limit, while SY (29.95%) and Seosan (29.93%) also settled at their price limits. Sejong Telecom and KPM Tech also continued their upward trend as strong buying interest flowed in from early in the session.

The market is noting that upper-limit stocks are not confined to a specific industry but are appearing across diverse sectors such as biotech, chemicals, telecommunications, and construction. This is interpreted as a signal that market conditions persist where individual corporate catalysts and supply-demand dynamics, rather than the overall index direction, dictate short-term stock prices.

However, some caution that upper-limit stocks can experience significantly expanded volatility in the short term, advising a prudent approach—checking volume changes, disclosures, and the company's actual business fundamentals—rather than chasing prices.

[This article was written with AI assistance. AI was utilized in the writing process, and the final content was reviewed based on factual accuracy. This article does not constitute investment advice for any specific public offering, and responsibility for investment decisions lies solely with the investor.]

Wooil Shim
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.